21 Although the long-term retinal effects of GLP-1RA in DR arent fully understood at this time, an ongoing trial is investigating the extended effect of semaglutide on DR after 5 years of treatment
This increased risk may be related to the underlying disease process and not to any medication used for treatment Multiple endocrine neoplasia (MEN) is a rare genetic disorder that affects the endocrine system
combination injectable therapy should be considered as initial therapy for patients with a blood glucose of 300 mg/dL or higher, patients with an A1C of 10% or higher, and patients who are markedly symptomatic
In rare cases (for example, certain alcohol-based perfumes or recipient-specific local fees), additional local charges may be assessed by the carrier and would be payable by the recipient
Physicians & Healthcare Providers Liability and prescribing boundaries: Doctors offering integrative, anti-aging, or sports medicine have faced legal and regulatory grey areas when prescribing Category 2 compounds
The results suggest that a person could lose 47% more weight with tirzepatide versus semaglutide